Keyphrases
Colon
73%
Colitis
66%
Plasmacytoid Dendritic Cells
66%
Cholinergic Anti-inflammatory Pathway
66%
Nicotinic Acetylcholine Receptor (nAChR)
66%
Ulcerative Colitis
53%
Oxazolone-induced Colitis
53%
Nicotine
40%
Cholinergic Regulation
33%
Mouse Colon
33%
Mucosal Repair
33%
BLT1
33%
Electrolyte Transport
33%
Allergic Inflammation
33%
Intestinal Epithelial Cells
33%
CCL21
26%
Oxazolone
26%
Isolated Lymphoid Follicles
26%
Methyllycaconitine
26%
Immune Cells
20%
Food Allergy
19%
Cholinergic Pathway
18%
Therapeutic Effect
13%
Therapeutic Potential
13%
Cholinergic Nerves
13%
Ulcerative Colitis Patient
13%
Chronic Inflammatory Bowel Disease
13%
Th2 Cytokines
13%
Balb C Mice
13%
Innovative Therapies
13%
JAK2 Inhibitor
13%
Caspase-3 Inhibitor
13%
Stimulants
13%
Nerve Fibers
13%
Bone Marrow Cells
13%
Pathophysiological Roles
13%
Rac1
13%
2-Deoxy-d-glucose (2-DG)
13%
Anti-inflammatory Effect
13%
Wound Repair
11%
Leukotriene B4 (LTB4)
11%
Mucosal Injury
11%
Acetylcholine
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cholinergic Receptor Stimulating Agent
100%
Oxazolone
66%
Anti-Inflammatory Drug
66%
Colitis
66%
Nicotinic Receptor
55%
Ulcerative Colitis
55%
Inflammation
33%
Food Allergy
33%
Methyllycaconitine
22%
Acetylcholine
16%
N Benzyl 2 Cyano 3 (3,4 Dihydroxyphenyl)acrylamide
11%
Therapeutic Effect
11%
Janus Kinase 2 Inhibitor
11%
Bagg Albino Mouse
11%
Caspase 3 Inhibitor
11%
Inflammatory Bowel Disease
11%
Cytokine
11%
Glucose
11%
Antiinflammatory Activity
11%
Prednisolone
8%
Potassium Ion
8%
Neurotransmitter
8%
Immunology and Microbiology
Colon
33%
Allergic Inflammation
33%
Electrolyte Transport
33%
Wound Healing
33%
Leukotriene B4
25%
Immunocompetent Cell
16%
Food Allergy
13%
Chemokine
8%
Cytokine
8%
Mediator
8%
Enteritis
8%
Secretion (Process)
6%